Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 11/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | ELOVL6 | Q9H5J4 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3137183 | 0.85 | CACNA1B (0.44) | CACNA1BNR1I2CYP3A4CHRM2 | |
| SCHEMBL3030174 | 0.83 | CACNA1B (0.60) | CACNA1BNR1I2CYP3A4ELOVL6 | |
| SCHEMBL3122929 | 0.82 | CACNA1B (0.44) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3039658 | 0.80 | CACNA1B (0.48) | CACNA1BNR1I2CYP3A4CHRM2CCR5 | |
| SCHEMBL3133592 | 0.80 | CACNA1B (0.57) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3264873 | 0.79 | CACNA1B (0.48) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3123172 | 0.79 | CACNA1B (0.43) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3032687 | 0.78 | CACNA1B (0.69) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3035677 | 0.78 | CACNA1B (0.69) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3126278 | 0.77 | CACNA1B (0.58) | CACNA1BNR1I2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2205083-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2010-07-14 | — | — | EP | claimed |
| WO-2009045382-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2009-04-09 | — | — | WO | claimed |